Thursday, August 23, 2007

HIV Therapy news - Maraviroc is coming

I've just hear it thru a grapevine what antiretroviral therapy of HIV is on the rise this year.

I'm speaking about Maraviroc (aka Selzentry). So hwo does it act? These agents target entry of HIV into host cells, and the lead compounds in this class are maraviroc and vicriviroc, both of which are in phase 3 study.

Sadly, what all I was able to gather. We'll hear more soon, I hope.

No comments: